ClassID:

21173

A61K2039/5252 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus inactivated (killed)

Recent Application in this class:
#601
20140120125
2014-05-01

Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation

#602
20140107207
2014-04-17

Method for inactivating viruses with slightly acidic arginine

#603
20140086952
2014-03-27

Vaccine adjuvants from self-assembling peptides

#604
20140079733
2014-03-20

Compositions for canine respiratory disease complex

#605
20140056942
2014-02-27

Liquid stable virus vaccines

#606
20140056940
2014-02-27

Adjuvant compositions

#607
20140044752
2014-02-13

Inactivated virus compositions and methods of preparing such compositions

#608
20140037684
2014-02-06

Stabilizing excipient for inactivated whole virus vaccine

#609
20140023679
2014-01-23

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

#610
20140010844
2014-01-09

Tissue targeted antigenic activation of the immune response to treat cancers

#611
20140004193
2014-01-02

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

#612
20130344108
2013-12-26

Inactivated poliovaccine

#613
20130337012
2013-12-19

Tissue targeted antigenic activation of the immune response to treat cancers

#614
20130337010
2013-12-19

Reassortant BTV and AHSV vaccines

#615
20130337000
2013-12-19

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

#616
20130323277
2013-12-05

Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof

#617
20130315956
2013-11-28

Newcastle disease virus and the use thereof as a vaccine

#618
20130302360
2013-11-14

Mucosal adjuvant composition

#619
20130295126
2013-11-07

Vaccines for inclusion body hepatitis

#620
20130295097
2013-11-07

Human antibodies to Fel d1 and methods of use thereof

#621
20130287832
2013-10-31

Soluble needle arrays for delivery of influenza vaccines

#622
20130280295
2013-10-24

Aluminum compounds for use in therapeutics and vaccines

#623
20130280293
2013-10-24

Combination heptavalent vaccine

#624
20130273120
2013-10-17

Methods and compositions for intranasal delivery

#625
20130273100
2013-10-17

Vaccines with live bacterial isolates for systemic administration

#626
20130273099
2013-10-17

Prevention and treatment of sub-clinical PCVD

#627
20130266612
2013-10-10

Vaccine composition

#628
20130266603
2013-10-10

PCV/mycoplasma hyopneumoniae/PRRS combination vaccine

#629
20130266602
2013-10-10

PCV/combination vaccine

#630
20130266601
2013-10-10

vaccine

#631
20130209508
2013-08-15

Compositions containing amino acids, phosphate and manganese and their uses

#632
20130195915
2013-08-01

Influenza C virus and vaccine

#633
20130195910
2013-08-01

Vaccine delivery method

#634
20130189293
2013-07-25

Influenza hemagglutinin and neuraminidase variants

#635
20130177593
2013-07-11

Personalized site-specific immunomodulation

#636
20130171234
2013-07-04

Subunit vaccines for herpes viruses and methods of use

#637
20130164264
2013-06-27

Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles

#638
20130156813
2013-06-20

Biomarkers for prostate cancer and methods for their detection

#639
20130129781
2013-05-23

Methods and compositions for intranasal delivery

#640
20130129778
2013-05-23

Viral particles derived from an enveloped virus

#641
20130101612
2013-04-25

Vaccine for enveloped viruses

#642
20130084306
2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

#643
20130064867
2013-03-14

Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine

#644
20130058968
2013-03-07

Piscine reovirus immunogenic compositions

#645
20130052223
2013-02-28

Universal vaccine against H5N1 lineages

#646
20130052221
2013-02-28

DNA-PROTEIN VACCINATION PROTOCOLS

#647
20130052127
2013-02-28

Composite body for antigen or drug delivery

#648
20130045230
2013-02-21

COMPOSITION CONTAINING HCMV PARTICLES

#649
20130039946
2013-02-14

VACCINE COMPRISING AN ATTENUATED PESTIVIRUS

#650
20130039943
2013-02-14

NOVEL METHOD

#651
20130034582
2013-02-07

Reverse genetics methods for virus rescue

#652
20130028935
2013-01-31

COMPOSITION CONTAINING HCMV PARTICLES

#653
20130022631
2013-01-24

Vaccine for chikungunya virus infection

#654
20130011443
2013-01-10

Human respiratory syncytial virus vaccine

#655
20130011432
2013-01-10

Disrupted adenovirus-based vaccine against drugs of abuse

#656
20130004525
2013-01-03

Inactivating pathogens with oxidizing agents for vaccine production

#657
20120328654
2012-12-27

Multi-phase emulsions based on amphiphilic block copolymers

#658
20120315295
2012-12-13

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

#659
20120294889
2012-11-22

Chimeric Flavivirus Vaccines

#660
20120288522
2012-11-15

Pneumovirus compositions and methods for using the same

#661
20120276139
2012-11-01

USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS

#662
20120270292
2012-10-25

Photo-Inactivated Viruses and Systems and Methods of Using the Same

#663
20120259267
2012-10-11

Nanocarriers with multi-photon response elements

#664
20120258149
2012-10-11

Methods and compositions for the treatment of influenza

#665
20120258135
2012-10-11

Immunogenic anti-inflammatory compositions

#666
20120251572
2012-10-04

HEPATITIS C VIRUS VACCINE COMPOSITION

#667
20120244186
2012-09-27

Epinecidin-1 as a vaccine adjuvant for enhancing immune responses

#668
20120238001
2012-09-20

Production of viral vaccines in suspension on avian embryonic derived stem cell lines

#669
20120231033
2012-09-13

INACTIVATED POULTRY VACCINE

#670
20120231025
2012-09-13

Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions

#671
20120219587
2012-08-30

Process for producing influenza vaccine

#672
20120219584
2012-08-30

PROTECTION AGAINST PANDEMIC AND SEASONAL STRAINS OF INFLUENZA

#673
20120213813
2012-08-23

Alphavirus replicon particles as immunological adjuvants

#674
20120207853
2012-08-16

Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions

#675
20120207780
2012-08-16

Vaccine composition

#676
20120201849
2012-08-09

Vaccine stabilizer

#677
20120201845
2012-08-09

Transcutaneous immunization without heterologous adjuvant

#678
20120195937
2012-08-02

POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

#679
20120189645
2012-07-26

Compositions and methods to treat and control tumors

#680
20120178674
2012-07-12

MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM

#681
20120177686
2012-07-12

VACCINE FOR THE PREVENTION OF ACUTE LYMPHOBLASTIC LEUKEMIA

#682
20120177683
2012-07-12

Methods for preparing vesicles and formulations produced therefrom

#683
20120171249
2012-07-05

Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof

#684
20120164178
2012-06-28

Vaccine

#685
20120164176
2012-06-28

RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME

#686
20120164170
2012-06-28

Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof

#687
20120148666
2012-06-14

Anti-RSV immunogens and methods of immunization

#688
20120136142
2012-05-31

Adjuvant

#689
20120128716
2012-05-24

Vaccine Compositions

#690
20120128671
2012-05-24

NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES

#691
20120121690
2012-05-17

Method to enhance an immune response of nucleic acid vaccination

#692
20120121629
2012-05-17

Human rotavirus vaccine strains and diagnostics

#693
20120114694
2012-05-10

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

#694
20120107911
2012-05-03

Recombinant hemagglutinin protein of influenza virus and vaccine containing the same

#695
20120107354
2012-05-03

VIRAL VACCINE AND PROCESS FOR PREPARING THE SAME

#696
20120107353
2012-05-03

COMPOSITION

#697
20120107268
2012-05-03

Compositions and methods for modulating an immune response

#698
20120070464
2012-03-22

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

#699
20120064117
2012-03-15

Tetravalent influenza vaccine and use thereof

#700
20120058162
2012-03-08

Stable, spray dryed, immunogenic, viral compositions

#701
20120045469
2012-02-23

VACCINE

#702
20120045468
2012-02-23

Immunogenic compositions and uses thereof

#703
20120039956
2012-02-16

Dry storage stabilizing composition for biological materials

#704
20120039937
2012-02-16

Induction of an immune response against dengue virus using the prime-boost approach

#705
20120039934
2012-02-16

Adjuvant-sparing multi-dose influenza vaccination regimen

#706
20120039933
2012-02-16

Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine

#707
20120034630
2012-02-09

Circovirus sequences associated with piglet weight loss disease (PWD)

#708
20120034267
2012-02-09

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

#709
20120029437
2012-02-02

KITS FOR ONE-DOSE INTRADERMAL DELIVERY FOR NON-LIVE TRIVALENT INFLUENZA VACCINE

#710
20120027813
2012-02-02

ADJUVANTED INFLUENZA VACCINES FOR PEDIATRIC USE

#711
20120015425
2012-01-19

Cellular permissivity factor for viruses and uses thereof

#712
20120009654
2012-01-12

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

#713
20120009217
2012-01-12

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

#714
20120009215
2012-01-12

Influenza hemagglutinin and neuraminidase variants

#715
20120005768
2012-01-05

Circovirus sequences associated with piglet weight loss disease (PWD)

#716
20120003263
2012-01-05

RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA

#717
20110318407
2011-12-29

Inactivated dengue virus vaccine with aluminium-free adjuvant

#718
20110311586
2011-12-22

Materials and methods for respiratory disease control in canines

#719
20110311581
2011-12-22

Reverse genetics of negative-strand RNA viruses in yeast

#720
20110311578
2011-12-22

RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE

#721
20110305727
2011-12-15

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

#722
20110300604
2011-12-08

Recombinant influenza vectors with tandem transcription units

#723
20110287519
2011-11-24

High yield yellow fever virus strain with increased propagation in cells

#724
20110280905
2011-11-17

Live attenuated chimeric porcine circovirus vaccine

#725
20110274705
2011-11-10

Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells

#726
20110268828
2011-11-03

CELL RECEPTOR BLOCKER FOR PREVENTING AND TREATING AVIAN INFLUENZA AND OTHER DISEASES CAUSED BY VIRUSES

#727
20110262483
2011-10-27

METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS

#728
20110250232
2011-10-13

DNA transfection system for the generation of negative strand RNA virus

#729
20110243987
2011-10-06

Influenza vaccine

#730
20110236420
2011-09-29

Bluetongue virus recombinant vaccines and uses thereof

#731
20110236416
2011-09-29

FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF

#732
20110223198
2011-09-15

dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

#733
20110217327
2011-09-08

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#734
20110212129
2011-09-01

Method for Producing the Flu Virus

#735
20110212126
2011-09-01

Inactivated chimeric vaccines and related methods of use

#736
20110212124
2011-09-01

Vaccine Composition

#737
20110206726
2011-08-25

Combination vaccine with acellular pertussis

#738
20110200630
2011-08-18

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

#739
20110195093
2011-08-11

Tissue targeted antigenic activation of the immune response to treat cancers

#740
20110195091
2011-08-11

Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration

#741
20110195087
2011-08-11

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

#742
20110189231
2011-08-04

Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines

#743
20110189227
2011-08-04

PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF

#744
20110182940
2011-07-28

Method for producing purified influenza virus antigen

#745
20110182939
2011-07-28

Farnesoid-X-receptor antagonist as a vaccine adjuvant

#746
20110182936
2011-07-28

Influenza hemagglutinin and neuraminidase variants

#747
20110182935
2011-07-28

Prevention and treatment of sub-clinical PCVD

#748
20110182931
2011-07-28

Immortal avian cell line and methods of use

#749
20110177163
2011-07-21

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A

#750
20110177122
2011-07-21

DNA PRIME/ACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS

#751
20110177121
2011-07-21

Immunogenic Influenza Composition

#752
20110177119
2011-07-21

Stable, dried rotavirus vaccine, compositions and process for preparation thereof

#753
20110177116
2011-07-21

Methods of immunizing pregnant heifers at three months of gestation

#754
20110171253
2011-07-14

Astrovirus

#755
20110165224
2011-07-07

Vaccines for inclusion body hepatitis

#756
20110165189
2011-07-07

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

#757
20110159033
2011-06-30

West Nile Virus vaccine

#758
20110150929
2011-06-23

SARS vaccine compositions and methods of making and using them

#759
20110150928
2011-06-23

Avian reoviridae and vaccines thereof

#760
20110150926
2011-06-23

INFLUENZA VACCINES

#761
20110150770
2011-06-23

MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE

#762
20110135677
2011-06-09

Circovirus sequences associated with piglet weight loss disease (PWD)

#763
20110129494
2011-06-02

Vaccine formulations comprising saponin-containing adjuvants

#764
20110123568
2011-05-26

NOVEL USE

#765
20110123560
2011-05-26

Infectious bursal disease virus antigenic isolates and vaccines

#766
20110112509
2011-05-12

Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device

#767
20110110980
2011-05-12

HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN

#768
20110110975
2011-05-12

INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS

#769
20110104260
2011-05-05

Vaccine against varicella zoster virus

#770
20110091500
2011-04-21

Inactivated Live-Attenuated Bluetongue Virus Vaccine

#771
20110091499
2011-04-21

Treatment of pigs with PCV2 antigent

#772
20110081380
2011-04-07

Stabilizing excipient for inactivated whole virus vaccine

#773
20110081378
2011-04-07

COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS

#774
20110081376
2011-04-07

Method for using inactivated Japanese encephalitis virus particles as adjuvant

#775
20110070254
2011-03-24

MUTATIONS IN THE INFLUENZA A VIRUS NS1 GENE AND USE THEREOF

#776
20110064772
2011-03-17

Viral adjuvants

#777
20110059126
2011-03-10

Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity

#778
20110052633
2011-03-03

MULTI-PHASE EMULSIONS BASED ON AMPHIPHILIC BLOCK COPOLYMERS

#779
20110052619
2011-03-03

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

#780
20110052564
2011-03-03

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

#781
20110045059
2011-02-24

VACCINE AGAINST VARICELLA ZOSTER VIRUS

#782
20110045057
2011-02-24

Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof

#783
20110045024
2011-02-24

RNA VIRUS VACCINES AND METHODS

#784
20110045020
2011-02-24

Nucleic acid comprising chimeric gene derived from hepatitis C virus

#785
20110033489
2011-02-10

Circovirus sequences associated with piglet weight loss disease (PWD)

#786
20110027316
2011-02-03

Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same

#787
20110020908
2011-01-27

Monoparamunity inducers based on attenuated rabbit myxoma viruses

#788
20110020406
2011-01-27

Determination of antigenicity of an inactivated virus

#789
20110020401
2011-01-27

Tissue targeted antigenic activation of the immune response to treat cancers

#790
20110020393
2011-01-27

Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine

#791
20110020392
2011-01-27

PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

#792
20110020233
2011-01-27

Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof

#793
20110014239
2011-01-20

Preparation of vaccines using photosensitizer and light

#794
20110014234
2011-01-20

Methods of preparing myxomavirus compositions

#795
20110014233
2011-01-20

Psoralen-inactivated viral vaccine and method of preparation

#796
20110014232
2011-01-20

CHIMERIC FOOT AND MOUTH DISEASE VIRUSES

#797
20110014230
2011-01-20

PREPARATION OF INFLUENZA VIRUS VACCINE ANTIGENS

#798
20110014221
2011-01-20

HIV COMBINATION VACCINE AND PRIME BOOST

#799
20110014220
2011-01-20

Human respiratory syncytial virus (RSV) vaccine

#800
20110008387
2011-01-13

COMPOSITION CONTAINING HCMV PARTICLES

#801
20110002958
2011-01-06

Alphavirus Vectors for Respiratory Pathogen Vaccines

#802
20100330190
2010-12-30

IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

#803
20100330117
2010-12-30

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C

#804
20100322965
2010-12-23

VIRAL VACCINE VECTORS

#805
20100316673
2010-12-16

NANOEMULSION VACCINES

#806
20100316671
2010-12-16

Monoparamunity inducers based on attenuated rabbit myxomaviruses

#807
20100297176
2010-11-25

Polyinosinic acid-polycytidylic acid-based adjuvant

#808
20100291035
2010-11-18

Respiratory syncytial virus with a genomic deficiency complemented in trans

#809
20100285063
2010-11-11

Canine influenza virus and vaccine therefore

#810
20100285059
2010-11-11

Cytomegalovirus vaccines and methods of production

#811
20100273238
2010-10-28

Cellular permissivity factor for viruses and uses thereof

#812
20100272752
2010-10-28

Vaccine for viruses that cause persistent or latent infections

#813
20100266629
2010-10-21

Cattle reproductive disease vaccines

#814
20100266628
2010-10-21

Macrocyclic lactone combination compositions, vaccines and methods for producing same

#815
20100260797
2010-10-14

Influenza composition

#816
20100260795
2010-10-14

Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals

#817
20100239606
2010-09-23

Two-Step Temperature Profile for the Propagation of Viruses

#818
20100233208
2010-09-16

Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics

#819
20100233204
2010-09-16

Immunogenic Compositions and Methods for Treating and Preventing Animal Infections

#820
20100233201
2010-09-16

Polyanionic polymer adjuvants for B saccharide vaccines

#821
20100226937
2010-09-09

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

#822
20100226934
2010-09-09

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#823
20100221285
2010-09-02

Method of Immunization Against the 4 Dengue Serotypes

#824
20100221284
2010-09-02

NOVEL VACCINE COMPOSITION

#825
20100221283
2010-09-02

Circovirus sequences associated with piglet weight loss disease (PWD)

#826
20100221276
2010-09-02

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#827
20100215690
2010-08-26

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#828
20100209455
2010-08-19

Thermal inactivation of rotavirus

#829
20100209453
2010-08-19

CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#830
20100203081
2010-08-12

Recoding method that removes inhibitory sequences and improves HIV gene expression

#831
20100203072
2010-08-12

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#832
20100196495
2010-08-05

DELIVERY OF FLU ANTIBODIES TO SURFACES IN CONTACT WITH AIR

#833
20100189746
2010-07-29

Adaptation of Pitman Moore strain of rabies virus to primary chick embryo fibroblast cell cultures

#834
20100189743
2010-07-29

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#835
20100189736
2010-07-29

Circovirus sequences associated with piglet weight loss disease (PWD)

#836
20100189735
2010-07-29

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#837
20100189734
2010-07-29

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#838
20100189733
2010-07-29

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#839
20100189732
2010-07-29

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#840
20100183671
2010-07-22

LOW-ADDITIVE INFLUENZA VACCINES

#841
20100183667
2010-07-22

Vaccine Comprising an Oil in Water Emulsion Adjuvant

#842
20100183664
2010-07-22

Attenuated recombinant newcastle disease virus and vaccine containing the same

#843
20100172924
2010-07-08

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#844
20100166791
2010-07-01

CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)

#845
20100158946
2010-06-24

Secretory IgA and IgG Antibody Inducer

#846
20100158940
2010-06-24

MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES

#847
20100150963
2010-06-17

Yeast-based therapeutic for chronic hepatitis C infection

#848
20100150960
2010-06-17

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE

#849
20100150954
2010-06-17

Vaccines against influenza virus

#850
20100145015
2010-06-10

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

#851
20100136055
2010-06-03

Chimeric pestiviruses

#852
20100104562
2010-04-29

Enhancing efficacy of vaccines administered via the respiratory tract

#853
20100092940
2010-04-15

Method and Device for Detecting Feline Immunodeficiency Virus

#854
20100092512
2010-04-15

Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection

#855
20100086566
2010-04-08

Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59

#856
20100080844
2010-04-01

Method to enhance an immune response of nucleic acid vaccination

#857
20100080826
2010-04-01

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

#858
20100074919
2010-03-25

Circovirus sequences associated with piglet weight loss disease (PWD)

#859
20100074918
2010-03-25

VACCINE

#860
20100068225
2010-03-18

Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof

#861
20100068223
2010-03-18

Storage of Influenza Vaccines Without Refrigeration

#862
20100062019
2010-03-11

NEW VACCINE FORMULATIONS

#863
20100062014
2010-03-11

H3 equine influenza A virus

#864
20100055122
2010-03-04

Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof

#865
20100047279
2010-02-25

IMMUNOLOGICAL COMPOSITION

#866
20100047278
2010-02-25

Human rotavirus and vaccine composition comprising same

#867
20100041023
2010-02-18

Inactivated FCV vaccines

#868
20100040647
2010-02-18

Inactivated polio vaccines

#869
20100040642
2010-02-18

Peptide adjuvant for influenza vaccination

#870
20100034850
2010-02-11

Vaccine

#871
20100034830
2010-02-11

Rabies vaccine

#872
20100021497
2010-01-28

IPV-DPT vaccine

#873
20100015597
2010-01-21

PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE AND INHIBITION OF VIRAL REPLICATION

#874
20100010199
2010-01-14

MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS

#875
20090324645
2009-12-31

Production of vaccines

#876
20090324642
2009-12-31

Method of elicting or inducing an immune response

#877
20090324641
2009-12-31

Adjuvant compositions

#878
20090324640
2009-12-31

Neuraminidase-deficient live influenza vaccines

#879
20090311334
2009-12-17

MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT

#880
20090304799
2009-12-10

Nanoemulsion influenza vaccine

#881
20090304730
2009-12-10

Influenza vaccine

#882
20090304729
2009-12-10

Cell-derived viral vaccines with low levels of residual cell DNA

#883
20090297558
2009-12-03

Inactivated influenza virus compositions

#884
20090288179
2009-11-19

Inactivated nodavirus vaccine

#885
20090285854
2009-11-19

FROZEN STOCKPILING OF INFLUENZA VACCINES

#886
20090269282
2009-10-29

Methods for treating, preventing and diagnosing procine ttv infection

#887
20090263424
2009-10-22

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

#888
20090263423
2009-10-22

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

#889
20090263422
2009-10-22

INFLUENZA VACCINE

#890
20090263417
2009-10-22

Multi-subtype FIV vaccines

#891
20090258035
2009-10-15

AVIAN VIRUS VACCINES AND USES THEREOF

#892
20090246223
2009-10-01

Inactivated Chimeric Vaccines and Related Methods of Use

#893
20090226489
2009-09-10

Viral vaccine composition, process and methods of use

#894
20090226488
2009-09-10

VACCINE COMPRISING AN ATTENUATED PESTIVIRUS

#895
20090220545
2009-09-03

Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen

#896
20090214590
2009-08-27

Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof

#897
20090202590
2009-08-13

Influenza vaccines extemporaneously adsorbed to aluminium adjuvants

#898
20090202492
2009-08-13

ADENOVIRUS VACCINE UTILIZING IKK AS ADJUVANT

#899
20090191158
2009-07-30

Cloned defective interfering influenza A virus

#900
20090162918
2009-06-25

Circovirus sequences associated with piglet weight loss disease (PWD)